Charles River Laboratories International Inc. (CRL) Stock | News

CRL · Health Care · United States United States

Charles River Laboratories International Inc. (CRL) is a company in the Health Care sector, based in United States. The stock is held in 10 ETFs we track – with its largest weight of 0.14 % in ZPRS (msci-world-small-cap). That means you can hold Charles River Laboratories International indirectly and diversified through an ETF savings plan.

Average ETF coverage: 10 of the 95 ETFs we cover hold Charles River Laboratories International, spread across 4 indices. That puts the stock in more ETFs than 65.4 % of the 4,362 stocks we cover.

Held in10 ETFs
Highest weight0.14 %
Indices4
SectorHealth Care
CountryUnited States
ISINUS1598641074

Data note 1

Price chart

Data note 2

Performance

Performance
Year to date+45.8 %1 year+80.3 %
1 month+31.6 %3 months+79.4 %
Calendar year 2025+8.1 %
Calendar year 2026+47.9 %
52W

Data note 3

Risk metrics

Max drawdown-54.8 %
Volatility p.a.49.8 %
Best year2026: +47.9 %
Worst year2025: +8.1 %

Data note 4

Correlated with

The strongest co-movers on top, the most inverse below. Low or negative values improve portfolio diversification.

Data note 5

Key financials

Latest reported fiscal year (FY2025, period end 2025-12-27) as filed with the SEC.

Revenue4.0 bn $
Net income-0.1 bn $
Diluted EPS-2.91 $
Net margin-3.6 %
Return on equity-4.6 %
Equity ratio44.4 %
Revenue growth-0.9 %
Revenue and profit by fiscal year
Fiscal yearRevenueNet incomeMargin
FY20234.10.511.5 %
FY20244.00.00.5 %
FY20254.0-0.1-3.6 %

Data note 6

Figures in USD bn. Source: SEC EDGAR (XBRL annual filings, public domain). US-listed SEC filers only.

Held in these ETFs

Data note 7

Want to know how much Charles River Laboratories International Inc. overlaps with the rest of your portfolio? Use the Portfolio X-Ray or the ETF overlap check.

Stocks with similar ETF exposure

Names that reach a portfolio through largely the same funds as Charles River Laboratories International — the figure counts the ETFs holding both.

Data note 8

Latest Investment Intelligence News: Stocks